Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $57.65 M
According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are $57.65 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $57.65 M | 449.86% |
| 2022-12-31 | $10.48 M | |
| 2021-08-31 | $11.48 M | -2.31% |
| 2020-08-31 | $11.75 M | -23.03% |
| 2019-08-31 | $15.27 M | -6.23% |
| 2018-08-31 | $16.28 M | -16.38% |
| 2017-08-31 | $19.47 M | 17.03% |
| 2016-08-31 | $16.64 M | 990.43% |
| 2015-08-31 | $1.52 M | 51.24% |
| 2014-08-31 | $1 M | 90.74% |
| 2013-08-31 | $0.52 M | -65.12% |
| 2012-08-31 | $1.51 M | 151.96% |
| 2011-08-31 | $0.6 M | -3% |
| 2010-08-31 | $0.62 M | 20.35% |
| 2009-08-31 | $0.51 M | -43.58% |
| 2008-08-31 | $0.91 M | -35.82% |
| 2007-08-31 | $1.42 M | 133.86% |
| 2006-08-31 | $0.6 M | 1221.76% |
| 2005-08-31 | $0.04 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $28.94 B | 50,099.11% | 🇩🇰 Denmark |
 Sanofi SNY | $57.61 B | 99,821.95% | 🇫🇷 France |
 Ultragenyx RARE | $1.21 B | 2,008.29% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.13 B | 136.43% | 🇺🇸 USA |
 Compugen CGEN | $55.77 M | -3.27% | 🇮🇱 Israel |